Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.
Int J Mol Sci. 2023 Jul 21;24(14):11774. doi: 10.3390/ijms241411774.
The chimeric EWSR1::FLI1 transcription factor is the main oncogenic event in Ewing sarcoma. Recently, it has been proposed that EWSR1::FLI1 levels can fluctuate in Ewing sarcoma cells, giving rise to two cell populations. EWSR1::FLI1 cells present a migratory and invasive phenotype, while EWSR1::FLI1 cells are more proliferative. In this work, we described how the CD44 standard isoform (CD44s), a transmembrane protein involved in cell adhesion and migration, is overexpressed in the EWSR1::FLI1 phenotype. The functional characterization of CD44s (proliferation, clonogenicity, migration, and invasion ability) was performed in three doxycycline-inducible Ewing sarcoma cell models (A673, MHH-ES1, and CADO-ES1). As a result, CD44s expression reduced cell proliferation in all the cell lines tested without affecting clonogenicity. Additionally, CD44s increased cell migration in A673 and MHH-ES1, without effects in CADO-ES1. As hyaluronan is the main ligand of CD44s, its effect on migration ability was also assessed, showing that high molecular weight hyaluronic acid (HMW-HA) blocked cell migration while low molecular weight hyaluronic acid (LMW-HA) increased it. Invasion ability was correlated with CD44 expression in A673 and MHH-ES1 cell lines. CD44s, upregulated upon EWSR1::FLI1 knockdown, regulates cell migration and invasion in Ewing sarcoma cells.
嵌合 EWSR1::FLI1 转录因子是尤因肉瘤的主要致癌事件。最近,有人提出 EWSR1::FLI1 水平在尤因肉瘤细胞中可能波动,从而产生两种细胞群。EWSR1::FLI1 细胞表现出迁移和侵袭表型,而 EWSR1::FLI1 细胞则更具增殖能力。在这项工作中,我们描述了跨膜蛋白 CD44 标准同工型(CD44s)如何在 EWSR1::FLI1 表型中过表达,CD44s 参与细胞黏附和迁移。在三个诱导型 EWSR1::FLI1 尤因肉瘤细胞模型(A673、MHH-ES1 和 CADO-ES1)中,对 CD44s(增殖、集落形成、迁移和侵袭能力)的功能特征进行了描述。结果表明,CD44s 的表达降低了所有测试细胞系的细胞增殖,而不影响集落形成。此外,CD44s 增加了 A673 和 MHH-ES1 中的细胞迁移,但在 CADO-ES1 中没有影响。由于透明质酸是 CD44s 的主要配体,因此还评估了其对迁移能力的影响,结果表明高分子量透明质酸(HMW-HA)阻断了细胞迁移,而低分子量透明质酸(LMW-HA)则增加了细胞迁移。侵袭能力与 A673 和 MHH-ES1 细胞系中 CD44 的表达相关。在 EWSR1::FLI1 敲低后上调的 CD44s 调节尤因肉瘤细胞的迁移和侵袭。